Gracell Biotechnologies Inc. (NASDAQ:GRCL) Q3 2023 Earnings Convention Name November 13, 2023 8:00 AM ET

Firm Individuals

William Cao – Chairman and CEO

Wendy Li – Chief Medical Officer

Kevin Xie – CFO

Convention Name Individuals

Yigal Nochomovitz – Citi

Benjamin Burnett – Stifel

Dev Prasad – Jefferies

Eric Schmidt – Cantor

Emily Bodnar – H.C. Wainwright

Yanan Zhu – Wells Fargo Securities

Joseph Catanzaro – Piper Sandler

Justin Zelin – BTIG


Women and gents, thanks for standing by. Welcome to Gracell Biotechnologies Third Quarter 2023 Convention Name. At the moment, all contributors are in a listen-only mode. After opening remarks, we are going to open the decision for questions. Directions for queuing up will likely be given at the moment.

I’ll now flip the convention name over to Dr. Kevin Xie, Chief Monetary Officer. Please go forward.

Kevin Xie

Good morning, and welcome to Gracell third quarter 2023 company replace convention name and webcast. With me immediately are Gracell Founder and Chief Govt Officer, Dr. William Cao; and our Chief Medical Officer, Dr. Wendy Li. We’re excited to debate the development of the trials underway with our CAR-T candidate on immediately’s name.

We’re wanting ahead to share with you our current enterprise developments and upcoming targets as now we have six weeks remaining in 2023 and are wanting ahead to 2024. As a reminder, we’ll conduct a question-and-answer session following our formal remarks.

This morning, Gracell issued a press launch saying unaudited monetary outcomes for the third quarter ended September 30, 2023. We encourage everybody to learn this press launch, I wish to remind you that this name is being recorded for replay. Please be aware that for sure info mentioned on the decision immediately, together with monetary knowledge, scientific knowledge, future plans of our program, useful resource administration will likely be making forward-looking statements.


Source link